1,051
Views
15
CrossRef citations to date
0
Altmetric
Psoriasis and atopic dermatitis

Concomitant atopic dermatitis and psoriasis – a retrospective review

, , , , &
Pages 716-720 | Received 12 Nov 2019, Accepted 21 Nov 2019, Published online: 18 Dec 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Li Liu, Jie Chen, Kangheng Tang, Feng Li, Si Li & Xiaojie Ding. (2023) Pustular Psoriasis in a Patient Treated with Dupilumab for Atopic Dermatitis: A Case Report. Clinical, Cosmetic and Investigational Dermatology 16, pages 2217-2221.
Read now
Galina Balakirski, Sven-Niklas Burmann, Silke C. Hofmann & Alexander Kreuter. (2023) Paradoxical tralokinumab-induced psoriasis in a patient with atopic dermatitis. Journal of Dermatological Treatment 34:1.
Read now
Luigi Gargiulo, Luciano Ibba, Giulia Pavia, Jessica Avagliano, Andrea Cortese, Antonio Costanzo & Alessandra Narcisi. (2023) Upadacitinib for the treatment of concomitant psoriasis and atopic dermatitis: a case series. Journal of Dermatological Treatment 34:1.
Read now
Andrea Chiricozzi, Francesco Bellinato, Paolo Romita & Paolo Gisondi. (2022) Psoriasis: talking points from recent clinical trials. Expert Opinion on Investigational Drugs 31:12, pages 1265-1267.
Read now

Articles from other publishers (11)

M. Pascual Ares, A. Orbea Sopeña, A. Aramburu González & J. Gardeazábal García. (2023) Tratamiento biológico combinado en 2 pacientes con psoriasis y dermatitis atópica graves. Actas Dermo-Sifiliográficas.
Crossref
Jeong Eun Kim, Jongmi Lee, Yun Jung Huh, Katherine Kim, Vasuma Chaparala, James G. Krueger & Jaehwan Kim. (2023) Genomic Profiling of the Overlap Phenotype between Psoriasis and Atopic Dermatitis. Journal of Investigative Dermatology.
Crossref
Kouya Yamaki, Taichi Egi, Kouki Segawa, Ayano Tomonaka, Yusuke Nakai & Yutaka Koyama. (2023) Co-induced allergic response to an unrelated allergen exacerbates imiquimod-induced psoriasis in mice. Biological and Pharmaceutical Bulletin.
Crossref
Zheng Su & Yue-Ping Zeng. (2023) Dupilumab-Associated Psoriasis and Psoriasiform Manifestations: A Scoping Review. Dermatology 239:4, pages 646-657.
Crossref
Nicoletta Bernardini, Nevena Skroza, Giovanni Rossi, Alessandra Mambrin, Ersilia Tolino, Federica Marraffa, Martina Caviglia, Antonio Di Guardo, Salvatore Volpe, Ilaria Proietti & Concetta Potenza. (2022) Long term efficacy, safety, and tolerability of tildrakizumab in epileptic patient with psoriasis and eczema. Dermatology Reports 14:4.
Crossref
Matteo Megna, Lucia Genco, Matteo Noto, Cataldo Patruno, Gabriella Fabbrocini & Maddalena Napolitano. (2022) Eczematous eruption after brodalumab successfully treated with guselkumab and dupilumab. Dermatologic Therapy 35:11.
Crossref
Leyao Shi, Chen Liu, Huabao Xiong & Dongmei Shi. (2022) Elevation of IgE in patients with psoriasis: Is it a paradoxical phenomenon?. Frontiers in Medicine 9.
Crossref
Ya-Chu Tsai & Tsen-Fang Tsai. (2022) Overlapping Features of Psoriasis and Atopic Dermatitis: From Genetics to Immunopathogenesis to Phenotypes. International Journal of Molecular Sciences 23:10, pages 5518.
Crossref
Jing Gao, Xue Shen, Randy Ko, Cong Huang & Changbing Shen. (2021) Cognitive Process of Psoriasis and Its Comorbidities: From Epidemiology to Genetics. Frontiers in Genetics 12.
Crossref
A. Cunliffe, S. Gran, U. Ali, D. Grindlay, S. J. Lax, H. C. Williams & E. Burden‐Teh. (2021) Can atopic eczema and psoriasis coexist? A systematic review and meta‐analysis. Skin Health and Disease 1:2.
Crossref
E. Forward, G. Lee & G. Fischer. (2020) Shades of grey: what is paediatric psoriasiform dermatitis and what does it have in common with childhood psoriasis?. Clinical and Experimental Dermatology 46:1, pages 65-73.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.